Randomized phase IIb study of nivolumab (anti-PD-1; BMS-936558, ONO-4538) alone or in combination with ipilimumab versus bevacizumab in patients (pts) with recurrent glioblastoma (GBM).
Published
Conference Paper
Full Text
Duke Authors
Cited Authors
- Sampson, JH; Vlahovic, G; Desjardins, A; Friedman, HS; Baehring, JM; Hafler, D; Rollin, L; Coric, V; Perez, SN; Reardon, DA
Published Date
- May 20, 2014
Published In
Volume / Issue
- 32 / 15_suppl
Start / End Page
- TPS2101 - TPS2101
Published By
Electronic International Standard Serial Number (EISSN)
- 1527-7755
International Standard Serial Number (ISSN)
- 0732-183X
Digital Object Identifier (DOI)
- 10.1200/jco.2014.32.15_suppl.tps2101